Blog
Biomea Fusion (BMEA) Q2 Loss Drops 44%
Biomea Fusion (NASDAQ:BMEA), a biotechnology firm focused on developing covalent inhibitors for metabolic diseases, released its second quarter 2025 results on August 5, 2025. Net loss attributable
Orthofix (OFIX) Q2 Revenue Rises 2%
Orthofix Medical (NASDAQ:OFIX), a medical device and biologics company specializing in spinal, orthopedic, and bone growth products, reported results for Q2 2025 that modestly beat expectations on
Rivian (RIVN) Q2 Revenue Rises 12%
Rivian Automotive (NASDAQ:RIVN), the electric vehicle startup known for its adventure-oriented trucks and SUVs, released its earnings for the second quarter of fiscal 2025 on August 5, 2025. The
Clearway Energy (CWEN) Q2 Net Jumps 200%
Clearway Energy (NYSE:CWEN), a major U.S. independent power producer focused on wind, solar, and battery energy storage, released its fiscal second quarter 2025 results on August 5, 2025, and
Nuvectis (NVCT) Q2 Loss Widens 43%
Nuvectis Pharma (NASDAQ:NVCT), a clinical-stage biopharmaceutical company focused on cancer therapies, released its second quarter 2025 earnings on August 5, 2025. The most important news was the
Arista (ANET) Q2 Revenue Jumps 30%
Arista Networks (NYSE:ANET), known for its advanced data center networking hardware and software, delivered standout results in its earnings report released on August 5, 2025. The company posted
American Well (AMWL) Q2 Revenue Up 13%
American Well (NYSE:AMWL), a major telehealth solutions provider, reported second-quarter 2025 results on August 5, 2025. The standout detail: GAAP revenue of $70.9 million in Q2 2025 outpaced
Clover Health (CLOV) Q2 Sales Up 34%
Clover Health Investments (NASDAQ:CLOV), a technology-focused Medicare Advantage insurer, reported its Q2 2025 results on August 5, 2025. The most notable news was robust revenue growth, with GAAP
OraSure (OSUR) Q2 Revenue Falls 43%
OraSure Technologies (NASDAQ:OSUR), a diagnostics and sample collection device company, released its second quarter 2025 results on August 5, 2025. The earnings showed that GAAP revenue was $31.2
Cadence (CDNS) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Monday, July 28, 2025 at 5 p.m. ET
For analyst commentary, contact [email protected]
Source Fool.com
DigitalOcean (DOCN) Q2 Revenue Jumps 14%
DigitalOcean (NYSE:DOCN), a cloud computing company known for its simple, developer-friendly approach, reported its Q2 2025 results on August 5, 2025. The company’s earnings release featured GAAP
Molson Coors (TAP) Q2 EPS Jumps 12%
Molson Coors Beverage (NYSE:TAP), the global brewer behind brands like Coors Light, Miller Lite, and Blue Moon, released its Q2 2025 earnings results on August 5, 2025. The company reported non-GAAP
Hamilton Lane (HLNE) Q1 EPS Falls 13%
Hamilton Lane (NASDAQ:HLNE), a leading private markets investment manager with both discretionary and advisory assets, released its fiscal first quarter 2026 results on August 5, 2025. The main
AdaptHealth (AHCO) Q2 Revenue Falls 1%
AdaptHealth (NASDAQ:AHCO), a major provider of home medical equipment and related services, issued its second quarter 2025 results on August 5, 2025. The company reported lower GAAP revenue and net
OCUL Sales Drop 18%
Ocular Therapeutix (NASDAQ:OCUL), a biotechnology company developing therapies for eye diseases, reported its second quarter results on August 5, 2025. The earnings release pointed to a significant
Frontdoor (FTDR) Q2 Revenue Up 14%
Frontdoor (NASDAQ:FTDR), a leading provider of home warranties and home services, posted second quarter results on August 5, 2025. Frontdoor reported significant gains, with earnings per share of
Zeta Global (ZETA) Q2 Revenue Jumps 35%
Zeta Global (NYSE:ZETA), a provider of artificial intelligence (AI)-driven marketing technology, announced its Q2 2025 earnings results on August 5, 2025. The quarter was headlined by GAAP revenue
Life Time (LTH) Q2 EPS Jumps 48%
Life Time Group (NYSE:LTH), the premium health, fitness, and wellness club operator, reported its Q2 FY2025 results on August 5, 2025. The company delivered strong results, with adjusted earnings
Amgen (AMGN) Q2 Profit Jumps 21%
Amgen (NASDAQ:AMGN), a leading biotechnology company with a wide portfolio of innovative medicines, released its second-quarter 2025 results on August 5, 2025. The headline news was a double-digit
Myriad Genetics (MYGN) Q2 Revenue Up 6%
Myriad Genetics (NASDAQ:MYGN), a molecular diagnostics and precision medicine company known for genetic testing in oncology, women’s health, and mental health, released its Q2 2025 earnings on
This Arm-Backed Chipmaker Just Soared 98% on Day One -- Should You Buy the Hype?
The booming demand for artificial intelligence (AI) has opened the door for up-and-coming companies to enter the public markets.
Ambiq Micro (NYSE: AMBQ) is the latest initial public offering (IPO)
Carpenter Technology (CRS) Q4 2025 Earnings Call Transcript
Image source: The Motley Fool.
Thursday, July 31, 2025, at 10 a.m. ET
Need a quote from one of our analysts? Email [email protected]
Source Fool.com
Weyco (WEYS) Q2 Profit Drops 60%
Weyco Group (NASDAQ:WEYS), the company behind footwear brands like Florsheim and Nunn Bush, reported its financial results for the second quarter of fiscal 2025 on August 5, 2025. The quarter
WLKP Earnings Miss by 13%
Westlake Chemical Partners (NYSE:WLKP), a master limited partnership specializing in ethylene production, reported its second quarter results on August 5, 2025, covering the period ended June 30
Freshworks (FRSH) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Tuesday, July 29, 2025, at 5 p.m. ET
Need a quote from one of our analysts? Email [email protected]
Source Fool.com


